Autoantibodies to the Protein Core of Vascular Basement Membrane Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus

References

• Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Ann Rev Biochem 1991; 60: 443–475
   PubMed Web of Science ®Google Scholar
• Jackson R L, Busch S J, Cardin A D. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71: 481–539
   PubMed Web of Science ®Google Scholar
• Wagner W D. Proteoglycan structure and function as related to atherosclerosis. Ann N Y Acad Sci, K T Lee. NYAcad. Sci., New York 1985; 52–68
   Google Scholar
• Poole A R. Proteoglycans in health and disease: structures and functions. Biochem J 1986; 236: 1–14
   PubMed Web of Science ®Google Scholar
• Wight T N. Cell biology of arterial proteoglycans. Arterioscterosis 1989; 9: 1–20
   PubMedGoogle Scholar
• Faaber P, Rijke T PM, van de Putte L BA, Capel P JA, Berden J HM. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membrane. J Clin Invest 1986; 77: 1824–1830
   PubMed Web of Science ®Google Scholar
• Aotsuka S, Okawa-Takatsuji M, Kinoshita M, Yokohari R. Analysis of negatively charged dye-binding antibodies reactive with double-stranded DNA and heparan sulfate in serum from patients with rheumatic diseases. Clin Exp Immunol 1988; 73: 436–442
   PubMedGoogle Scholar
• Aotsuka S, Funahashi T, Tani N, Okawa-Takatsuji M, Kinoshita M, Yokohari R. Adsorption of anti-dsDNA antibodies by immunobilized polyanionic compounds. Clin Exp Immunol 1990; 79: 215–220
   PubMed Web of Science ®Google Scholar
• Termaat R M, Brinkman K, Nossent J C, Swaak A JG, Smeenk R JT, Berden J HM. Anti-heparan sulfate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations. Clin Exp Immunol 1990; 82: 268–274
   PubMedGoogle Scholar
• Sasaki T, Hatakeyama A, Shibata S, Osaki H, Suzuki M, Horie K, Kitagawa Y, Yoshinaga K. Heterogeneity of immune complex-derived anti-DNA antibodies associated with lupus nephritis. Kidney Int 1991; 39: 746–753
   PubMedGoogle Scholar
• Triolo G, Giardina E, Scarantino G, Seddio G, Cardella G, Meli F, Bompiani G. Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus. Diobetes 1989; 38: 718–722
   PubMedGoogle Scholar
• Abrass C K, Cohen A H. Characterization of renal injury initiated by immunization of rats with heparan sulfate. Am J Pathol 1988; 130: 103–111
   PubMed Web of Science ®Google Scholar
• van den Born J, van den Heuvel L PWJ, Bakker M AH, Veerkamp J H, Assrnann K JM, Berden J HM. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992; 41: 115–123
   PubMed Web of Science ®Google Scholar
• Kemeny E, Fillit H M, Danle S P, Mahabir R, Kefalides N A, Gregory J D, Antonovych T, Sabnis S, Zabriskie J B. Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissues and pathologic human kidney biopsies. Conn Tiss Res 1988; 18: 1–12
   PubMedGoogle Scholar
• Hassell J R, Robey P G, Banach H J, Wilezek J, Rennard S, Martin G R. Isolation of a heparan sulfate containing proteoglycan from basement membrane. Proc Notl Acad Sci USA 1980; 77: 4494–4498
   PubMed Web of Science ®Google Scholar
• Stow J L, Sawada J, Farquhar M G. Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 1985; 82: 3296–3301
   PubMed Web of Science ®Google Scholar
• Makino H, Gibbons J T, Rrddy M K, Kanwar Y S. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane-I. J Clin Invest 1986; 77: 142–156
   PubMed Web of Science ®Google Scholar
• Miettinen A, Stow J L, Mentone S, Farquhar M G. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 1986; 163: 1064–1084
   PubMed Web of Science ®Google Scholar
• Fillit H, Lahita R. Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus. Autoimmunity 1991; 9: 159–164
   PubMed Web of Science ®Google Scholar
• Fillit H, Damle S P, Gregory J D, Volin C, Poon-King T, Zabriskie J. Sera from patients with poststreptococcal glomeru-lonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med 1985; 161: 277–289
   PubMed Web of Science ®Google Scholar
• Misra R P. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Parhol 1972; 58: 135–139
   PubMed Web of Science ®Google Scholar
• Bitter T, Muir H M. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330–335
   PubMed Web of Science ®Google Scholar
• Edge A SB, Spiro R G. Selective deglycosylation of the heparan sulfate proteoglycan of bovine glomerular basement membrane and identification of the protein core. J Biol Chem 1987; 262: 6893–6898
   PubMed Web of Science ®Google Scholar
• Blake M S, Johnston K H, Russell-Jones G J, Gotschlich E C. A rapid, sensitive method for detection of alkaline phosphatase conjugated anti-antibody on Western blots. Anal Biochem 1984; 136: 175–179
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Freis J F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Mikecz K, Glant T T, Buzas E, Poole A R. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arth Rheum 1990; 33: 866–876
   PubMed Web of Science ®Google Scholar
• Dayer E, Mathai L, Glant T T, Mikecz K, Poole A R. Cartilage proteoglycan-induced arthritis in BALB/c mice. Arth Rheum 1990; 33: 1394–1405
   PubMed Web of Science ®Google Scholar
• Mikecz K, Glant T T, Baron M, Poole A R. Isolation of proteo-glycan-specific T lymphocytes from patients with ankylosing spondylitis. Cell Immunol 1988; 112: 55–63
   PubMedGoogle Scholar
• Noonan D M, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell J R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipo-protein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991; 266: 22939–22947
   PubMed Web of Science ®Google Scholar
• Matzner Y, Bar-Ner M, Yahalom J, Ishay-Michaeli R, Fuks Z, Vlodavsky I. Degradation of heparan sulfate in the sub-endothelial basement membrane by a readily released hepariti-nase from human neutrophils. J Clin Invest 1985; 76: 1306–1313
   PubMed Web of Science ®Google Scholar
• Fridman R, Lider O, Naparastek Y, Fuks Z, Vlodavsky I, Cohen I R. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol 1987; 130: 85–94
   PubMedGoogle Scholar
• Yahalom J, Eldor A, Fuks S, Vlodavsky I. Degradation of sulfate proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest 1984; 74: 1842–1849
   PubMedGoogle Scholar